Primary Job Title Founder and CEO Primary Organization 
Alopexx
Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Dr. Vlock is founder and CEO of Alopexx Enterprises, LLC, a healthcare company focused on investing and developing preclinical and early clinical compounds.
He is also CEO of Alopexx Pharmaceuticals, which developed a human monoclonal antibody directed against S. aureus. That antibody has completed a Phase 1 clinical trial and was licensed to
Sanofi-Aventis.
Dr. Vlock has held senior-level medical and research positions at Ariad Pharmaceuticals, GPC Biotech, Inc., and Pharmacia Corporation, where he ran the Celebrex Oncology Group and was responsible for this compound becoming the first drug approved for cancer prevention.
